Breast-chemotherapy
Showing 1 - 25 of >10,000
Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of
Not yet recruiting
- Organoids
- +2 more
- Biopsy
- (no location specified)
Nov 24, 2023
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
CIPN - Chemo-Induced Peripheral Neuropathy, Breast Cancer Trial (yoga)
Not yet recruiting
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Breast Cancer
- yoga
- (no location specified)
Jul 25, 2023
Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
- Epirubicin, Cyclophosphamide, Docetaxel
- (no location specified)
Jun 21, 2023
Breast Cancer Trial in Athens (Melatonin)
Completed
- Breast Cancer
- Melatonin
-
Athens, GreeceIaso Hospital
Nov 4, 2023
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
Breast Cancer Female Trial (Pyrotinib and Trastuzumab)
Not yet recruiting
- Breast Cancer Female
- Pyrotinib and Trastuzumab
- (no location specified)
Sep 11, 2023
Metastatic Breast Cancer Trial (Meritup oral solution)
Not yet recruiting
- Metastatic Breast Cancer
- Meritup oral solution
- (no location specified)
Nov 29, 2023
Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))
Not yet recruiting
- Breast Cancer
- Arm I (No PMRT)
- Arm II (PMRT)
- (no location specified)
Aug 8, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of
Not yet recruiting
- Triple Negative Breast Cancer
- +2 more
- Everolimus
- Investigator's Choice of Chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 25, 2023
Breast Cancer, Breast Tumors, Breast Cancer Female Trial in Istanbul (Axillary sentinal lymph node biopsy)
Not yet recruiting
- Breast Cancer
- +2 more
- Axillary sentinal lymph node biopsy
-
İstanbul, Bagcilar, Turkey
- +1 more
Oct 22, 2023
Micrometastases in Axillary Lymph Nodes in Breast Cancer,
Completed
- Micrometastases
- Neoadjuvant Chemotherapy
- Sentinel lymph node biopsy, axillary lymph node dissection
- (no location specified)
Nov 20, 2023
TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- Camrelizumab Plus Chemotherapy and Famitinib
- Camrelizumab Plus Chemotherapy
- (no location specified)
Aug 17, 2023
Breast Cancer Trial in Toronto (ICG guided sentinel lymph node biopsy)
Recruiting
- Breast Cancer
- ICG guided sentinel lymph node biopsy
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 13, 2023
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole
Recruiting
- Triple Negative Breast Cancer
- +3 more
- Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 15, 2023
Breast Cancer Female Trial in Bani Suwayf (MetFORMIN 500 Mg Oral Tablet, Chemotherapy)
Completed
- Breast Cancer Female
- MetFORMIN 500 Mg Oral Tablet
- Chemotherapy
-
Banī Suwayf, EgyptMarian S. Boshra
May 2, 2023
Breast Cancer Trial in Gainesville (12-week Intervention Period, 12-week Observation Period)
Not yet recruiting
- Breast Cancer
- 12-week Intervention Period
- 12-week Observation Period
-
Gainesville, FloridaIntegrative Cardiovascular Physiology Laboratory, University of
Jun 13, 2023
Young Patients With Early Breast Cancer
Not yet recruiting
- Breast Cancer Female
- operation
- (no location specified)
Sep 6, 2023
Breast Cancer, HER2-positive Breast Cancer Trial in São Paulo (PHESGO)
Not yet recruiting
- Breast Cancer
- HER2-positive Breast Cancer
-
São Paulo, BrazilCentro Paulista de Oncologia (Oncoclínicas)
Oct 3, 2023
Breast Cancer Survivors Trial in Gainesville (Exercise training)
Not yet recruiting
- Breast Cancer Survivors
- Exercise training
-
Gainesville, FloridaIntegrative Cardiovasculal Physiology Laboratory, University of
May 10, 2023
Breast Cancer Trial (SHR-A1811, Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel)
Not yet recruiting
- Breast Cancer
- (no location specified)
Apr 3, 2023
t Pathologic Complete Response Observed in HER2 Positive Breast
Completed
- HER2+ Breast Cancer
-
Rawalpindi, Punjab, PakistanRawalpindi Medical University
Jun 26, 2023
Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic
Completed
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2023